TJ Biopharma Co., Ltd.

Quick facts

Phase 3 pipeline

• NordiFlex · Oncology
  NordiFlex is a monoclonal antibody that targets the PD-1 receptor.
• TJ101
  TJ101 is a small molecule that targets the [insert target here, if known].
• TJ202, Lenalidomide and Dexamethasone · Oncology
  Lenalidomide is an immunomodulatory drug that stimulates the immune system to attack cancer cells, while dexamethasone is a corticosteroid that has anti-inflammatory and immunosuppressive properties.

Phase 2 pipeline

• TJ107
• TJ202 and Dexamethasone

Phase 1 pipeline

• TJ101 injection Reference Product
• TJ101 injection Test Product

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• TJ Biopharma Co., Ltd. portfolio CI brief
• TJ Biopharma Co., Ltd. pipeline updates RSS